The paperwork check for compounded medicine

Verify the paperwork.
Control the lot.
Prove every order.

Someone can fake the lab report behind a vial of compounded medicine, and a fake one looks exactly like a real one. Veritura reads that paperwork independently and tells you what is missing, reused, or edited, before you rely on it.

  • We do not sell what we check
  • We read the paperwork
  • We never grade the medicine
Sample data · Order evidenceEvidence posture: Clear
Evidence at a glance
PO-DEMO-0413LOT-7741-A
Evidence completeness
98%
Clear
Submitted files
6
Sample packet
Live connection
0
Offline
Evidence assemblyIllustrative
  • Lot aligned
  • Tests scoped
  • Source dated
  • Policy resolved

Evidence stays with the order

Packet · lot · policy · release

The problem

A forged certificate looks exactly like a real one.

Every vial starts as a stack of paperwork. The certificate of analysis, the lab report that says what is in the batch, is the document that gets copied, edited, or reused between shipments.

  • The same lot number, report ID, or file turns up across sellers that should not share one, and no single packet review can see it.

  • A recall can land months after the packet was filed, with nothing connecting it back to the lot, the order, or the person holding the vial.

  • When someone asks what was behind an order, the answer is spread across an inbox, a binder, and a spreadsheet.

What is at stake

One missing document.

One overlooked discrepancy.

One supplier change.

That is all it takes.

The workspace

One record, from receiving to release.

Saving a check upserts the lot and re-runs the release gate over every document on file for that subject and dosage form, not just the newest one. The documents, the disposition, the signed decision, the hashes and any later signal all hang on that lot.

See the platform
Sample workspace · not a live account

Quality desk

Dashboard

As of July 27, 2026

Orders screened

128

Quarter to date · 104 Allow, 18 Review, 6 Hold

ClearGate Allow

104

Documentation met the configured workspace policy

ClearGate Hold

6

Held on the evidence on file, not on a test result

Active suppliers

4

Qualification files under ongoing review

Orders over time

Last 12 weeks

Orders screenedClearGate Hold
Orders screened per week, twelve weeks128 orders screened across twelve weeks, from May 4 to Jul 20. Weekly volume runs between 6 and 15. 6 of them resolved to ClearGate Hold.0481216May 4May 18Jun 1Jun 15Jun 29Jul 13
  • Week of May 4: 6 screened, 0 on hold.
  • Week of May 11: 8 screened, 1 on hold.
  • Week of May 18: 7 screened, 0 on hold.
  • Week of May 25: 11 screened, 1 on hold.
  • Week of Jun 1: 9 screened, 0 on hold.
  • Week of Jun 8: 12 screened, 1 on hold.
  • Week of Jun 15: 10 screened, 0 on hold.
  • Week of Jun 22: 14 screened, 0 on hold.
  • Week of Jun 29: 13 screened, 1 on hold.
  • Week of Jul 6: 11 screened, 1 on hold.
  • Week of Jul 13: 15 screened, 0 on hold.
  • Week of Jul 20: 12 screened, 1 on hold.

Recent activity

  • LOT-7741-A released under policy

    Semaglutide (base) API · Aurora Pharma Supply · 6 documents on file

    10:32 AM

  • Sterility evidence requested

    LOT-KP-2407 · Keystone Peptide Labs · prefilled corrected-COA request sent

    9:18 AM

  • Lot identifier mismatch recorded

    LOT-BR-0816 · shipment label reads BR-0818 · verification route unreachable

    Yesterday, 4:06 PM

  • Evidence Passport issued

    V-SBX-00012 · Lidocaine HCl · LOT-MC-1129 · Meridian Compounding Source

    Yesterday, 2:44 PM

  • Public-source snapshot refreshed

    openFDA enforcement search re-run for 4 suppliers · no match in captured sources

    Yesterday, 6:00 AM

The artifact

The record that travels with the vial.

Scan the seal on the label and this is what opens. It states what the paperwork establishes, and who established each line.

Evidence Passport

veritura.co/verify

Serial

V-SBX-00013

Documentation

Documentation reads complete

Every required field was present on the documents for this lot, and no serious finding stood against them. A paperwork read, never a statement that the medicine is safe, effective, or approved.

Preparation
Semaglutide (base) API
Lot
LOT-7741-A
Quantity
250 g
Supplier
Aurora Pharma Supply
Received
July 22, 2026
Released
July 23, 2026

As documented on the certificate

Identity
Conforms
Purity (HPLC)
98.7%
Endotoxin
Below limit
Sterility
Not applicable

Values as printed by the issuing laboratory. Veritura reads and records them. It does not perform or repeat any test.

Where each line came from

  • Certificate of analysisSource-confirmed
  • Certificate of conformanceVeritura evaluated
  • Safety data sheetVeritura evaluated
Certificate read bySource-confirmed

Documents on file

6

Notices on this lot

None published

Veritura reads documentation. It does not grade the medicine, approve a supplier, or certify a product. Questions about your treatment stay with the pharmacy or prescriber who dispensed it.

Local sample data. Not a live account. Every supplier, lot, order, and document shown here is fictional.

The customer-facing Evidence Passport. Local sample data. Not a live account. Every supplier, lot, order, and document shown here is fictional.

Independent by construction

Why independent

Evidence without a product to sell.

Veritura does not sell, source, or distribute compounded product. It works across suppliers and keeps the submitted record, source context, policy result, and limitations inspectable.

  • No supplier ownership
  • No paid or subjective placement, and no purchase recommendation
  • No physical-product testing
  • No safety, legal, or FDA-approval determination
Why independence matters

Built around the operator

One evidence model. Different jobs.

503A pharmacy

Control evidence at receiving and release.

Connect the incoming packet, Receiving Gate, ClearGate decision, Living Formulary, lot record, and Evidence Passport.

See the full lane
  1. 1Scan the shipment label
  2. 2Resolve lot evidence
  3. 3Record disposition
  4. 4Issue customer-safe proof

"We trusted the certificate" is not an answer.

Walk one lot end to end: the read, the four lanes, the decision your policy produced, and the record you hand someone.

Document diligence only, never a safety or FDA-approval claim.

Veritura does not test medicine, approve suppliers, recommend purchases, or make medical, legal, product-safety, or FDA-approval determinations. There is no paid or subjective placement: suppliers cannot pay for a better result or a better position, no listing fee, no subscription, and no pay-to-rank. Where results are ordered rather than filtered, the order is set by a published documentation-coverage grade, and that grade is never a recommendation, a preference, or a statement about any product.

A COA check or Passport records whether the documents are complete and consistent. It is not a safety, quality, efficacy, legality, or FDA-approval claim.